These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14949019)

  • 1. Ineffectiveness of 688A (N-phenoxyisopropyl-N-benxyl-beta-chloroethylamine hydrochloride) in treatment of essential hypertension.
    CORCORAN AC; TAYLOR RD; HARRISON M
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):265-8. PubMed ID: 14949019
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical blockade of the sympathetic nervous system in essential hypertension; experience with oral therapy with 688-A (N-phenoxy isopropyl-N-benzyl-beta-chloroethylamine hydrochloride).
    MOSER M; WALTERS M; MASTER AM; TAYMOR RC; METRAUX J
    AMA Arch Intern Med; 1952 May; 89(5):708-23. PubMed ID: 14914211
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal hemodynamic and blood pressure response to n-phenoxyisopropyl-n-benzyl-beta-chlorethylamine (SKF 688A).
    MOYER JH; HANDLEY CA
    J Pharmacol Exp Ther; 1952 Mar; 104(3):329-33. PubMed ID: 14908903
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.
    MOYER JH
    AMA Arch Intern Med; 1953 Apr; 91(4):419-39. PubMed ID: 13039601
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral hemodynamic response to blood pressure reduction with phenoxybenzamine (dibenzyline-688A).
    MOYER JH; SNYDER H; MILLER SI
    Am J Med Sci; 1954 Nov; 228(5):563-7. PubMed ID: 13207118
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of oral 1-hydrazinophthalazine therapy on renal function in essential vascular hypertension.
    MADER IJ; ISERI L
    Am Heart J; 1955 Oct; 50(4):556-66. PubMed ID: 13258483
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of essential hypertension with bretylium tosylate].
    ENDERLE J
    Brux Med; 1961 Jan; 41():13-20. PubMed ID: 13696746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of hydrazinophthalazine on intrarenal hemodynamics in essential hypertension].
    DOERING P; KOCH R; KUHNS K; SCHWAB M
    Dtsch Arch Klin Med; 1954; 201(1):44-56. PubMed ID: 13173294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apresoline therapy of essential hypertension].
    BECHGAARD P; PAULSEN L
    Ugeskr Laeger; 1954 Aug; 116(33):1191-5. PubMed ID: 13205757
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of hydrazinophthalazine in essential hypertension].
    VIZZINI AA
    Hospital (Rio J); 1953 Dec; 44(6):775-82. PubMed ID: 13151634
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of essential hypertension with B-alkylamines, especially dibenzyline.
    BAKKE JL; WILLIAMS RH
    Am J Med; 1953 Feb; 14(2):141-59. PubMed ID: 13016596
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of oral 688A (N-phenoxy-isopropyl-N-benzyl-beta-chloroethylamine hydrochloride) on blood pressure in normotensive and hypertensive subjects.
    HAIMOVICI H; MOSER M; KRAKAUER H
    Proc Soc Exp Biol Med; 1951 Jul; 77(3):477-80. PubMed ID: 14864631
    [No Abstract]   [Full Text] [Related]  

  • 13. A new sympatholytic and adrenolytic drug; clinical studies on essential hypertension.
    BANNON WG
    Proc Staff Meet Mayo Clin; 1952 Nov; 27(24):475-81. PubMed ID: 13004019
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with adelphan therapy in 25 cases of essential hypertension].
    DEMEULENAERE L
    Belg Tijdschr Geneesk; 1955 Oct; 11(19):955-9. PubMed ID: 13283944
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential hypertension; treatment with hexamethonium and apresoline.
    SHAPERA RP; LANG FR
    U S Armed Forces Med J; 1953 Jun; 4(6):903-6. PubMed ID: 13049707
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of essential hypertension.
    EVANS JM
    Med Ann Dist Columbia; 1953 Sep; 22(9):456-8. PubMed ID: 13085968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemical experiences in the treatment of essential hypertension with ipharon].
    MAURER HE
    Med Klin; 1957 Sep; 52(39):1711-3. PubMed ID: 13483004
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute psychosis as a complication of hydralazine therapy in essential hypertension.
    MOSER M; SYNER J; MALITZ S; MATTINGLY TW
    J Am Med Assoc; 1953 Aug; 152(14):1329-31. PubMed ID: 13061271
    [No Abstract]   [Full Text] [Related]  

  • 19. A new sympatholytic and adrenolytic drug; clinical studies on pheochromocytoma and essential hypertension.
    ALLEN EV; BANNON WG; UPSON M; HUIZENGA KA; BASTRON JA; WAUGH JM
    Trans Assoc Am Physicians; 1951; 64():109-21. PubMed ID: 14884241
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
    STEEVES LC; SHEARS AH; SPELLER SL
    Treat Serv Bull; 1953 Oct; 8(9):573-8. PubMed ID: 13102592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.